Filing Details

Accession Number:
0001640455-21-000040
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-18 19:47:08
Reporting Period:
2021-02-16
Accepted Time:
2021-02-18 19:47:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1640455 Jounce Therapeutics Inc. JNCE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1581954 Duncan John Higgons C/O Jounce Therapeutics, Inc.
780 Memorial Drive
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-16 200 $11.78 10,113 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 21, 2020. The Reporting Person exercised no discretion with respect to these transactions.